| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |